X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9454) 9454
Publication (1520) 1520
Book Chapter (88) 88
Book Review (86) 86
Dissertation (28) 28
Conference Proceeding (22) 22
Magazine Article (12) 12
Newspaper Article (10) 10
Trade Publication Article (6) 6
Data Set (2) 2
Book / eBook (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5342) 5342
immunotherapy (4020) 4020
pd-1 (4017) 4017
humans (3640) 3640
oncology (3488) 3488
cancer (2937) 2937
immunology (2512) 2512
pd-1 protein (2163) 2163
lymphocytes (1982) 1982
tumors (1783) 1783
melanoma (1770) 1770
female (1665) 1665
nivolumab (1657) 1657
lymphocytes t (1599) 1599
pd-1 blockade (1594) 1594
expression (1588) 1588
animals (1581) 1581
apoptosis (1498) 1498
t cells (1482) 1482
male (1404) 1404
pd-l1 (1382) 1382
immune checkpoint (1274) 1274
pembrolizumab (1156) 1156
patients (1139) 1139
mice (1129) 1129
care and treatment (1093) 1093
pd-l1 protein (1092) 1092
middle aged (1089) 1089
chemotherapy (1085) 1085
ipilimumab (1041) 1041
metastasis (951) 951
t-cells (926) 926
blockade (922) 922
article (908) 908
research (901) 901
antigens (891) 891
ligands (888) 888
adult (867) 867
aged (859) 859
survival (826) 826
therapy (802) 802
safety (800) 800
ctla-4 (794) 794
lung cancer (784) 784
cell death (779) 779
immune system (775) 775
cancer therapies (744) 744
immune response (731) 731
analysis (730) 730
activation (725) 725
health aspects (722) 722
cd8 antigen (710) 710
cytotoxicity (704) 704
dendritic cells (692) 692
cell biology (677) 677
open-label (672) 672
anti-pd-1 (670) 670
programmed cell death 1 receptor - antagonists & inhibitors (666) 666
clinical trials (664) 664
gene expression (660) 660
metastases (646) 646
medicine, research & experimental (633) 633
biomarkers (625) 625
immunity (616) 616
prognosis (609) 609
programmed cell death 1 receptor - immunology (606) 606
responses (599) 599
flow cytometry (598) 598
antibodies (596) 596
metastatic melanoma (589) 589
programmed cell death 1 receptor - metabolism (582) 582
cd8-positive t-lymphocytes - immunology (575) 575
immunotherapy - methods (572) 572
cytokines (569) 569
mutation (565) 565
review (553) 553
medical research (548) 548
t-lymphocytes - immunology (543) 543
multidisciplinary sciences (531) 531
t cell receptors (526) 526
antibodies, monoclonal - therapeutic use (521) 521
immunohistochemistry (518) 518
tumor-infiltrating lymphocytes (514) 514
medicine & public health (498) 498
proteins (490) 490
cell lung-cancer (489) 489
medical prognosis (470) 470
cd4 antigen (469) 469
medicine (466) 466
genetic aspects (465) 465
exhaustion (464) 464
neoplasms - immunology (463) 463
regulatory t-cells (461) 461
b7-h1 antigen - metabolism (453) 453
treatment outcome (453) 453
antibody (452) 452
inflammation (452) 452
abridged index medicus (451) 451
pd-1 expression (447) 447
tumor microenvironment (446) 446
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9258) 9258
French (78) 78
German (77) 77
Chinese (46) 46
Japanese (24) 24
Korean (19) 19
Russian (18) 18
Polish (9) 9
Spanish (8) 8
Czech (5) 5
Hungarian (3) 3
Dutch (2) 2
Slovenian (2) 2
Persian (1) 1
Portuguese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Protein Expression and Purification, ISSN 1046-5928, 02/2020, Volume 166, p. 105520
An affibody is a 58 amino acids peptide derived from the Z domain of staphylococcal protein A and generally applied in areas such as imaging diagnosis,... 
Affibody | PD-1/PD-L1 | Yeast two hybrid
Journal Article
Multiple Sclerosis and Related Disorders, ISSN 2211-0348, 01/2020, Volume 37, p. 101447
While immune checkpoint inhibitors (ICIs) have contributed to the development of therapeutic treatments for previously incurable advanced malignancies, they... 
Anti-aquaporin-4 antibody | PD-1 monoclonnal antibody | Pembrolizumab | Neuromyelitis optica spectrum disorder | Immune checkpoint inhibitor | Immune-related adverse event
Journal Article
Biomedicine & Pharmacotherapy, ISSN 0753-3322, 01/2020, Volume 121
Unprecedented efficacy of chimeric antigen receptor (CAR) T cell therapy in the treatment of hematologic malignancies brings new hope for patients with many... 
Chimeric antigen receptor T cells | Immunotherapy | CAR-T cells | Gene editing | PD-1
Journal Article
IFMBE Proceedings, ISSN 1680-0737, 2020, Volume 69, pp. 619 - 625
Conference Proceeding
Molecular Therapy - Methods & Clinical Development, ISSN 2329-0501, 12/2019, Volume 15, pp. 83 - 100
The pro-tolerogenic environment of the liver makes this tissue an ideal target for gene replacement strategies. In other peripheral tissues such as the... 
LAG3 | gene transfer | liver | AAV | Tregs | peripheral tolerance | PD-1 | checkpoint inhibitors
Journal Article
Artificial Cells, Nanomedicine, and Biotechnology, ISSN 2169-1401, 12/2019, Volume 47, Issue 1, pp. 1036 - 1042
Previous studies have focused on the changes of tumour cells in immune escape, and less is known about the effect of tumour microenvironment (TME) on immune... 
TAF | immune escape | Gastric cancer | PD-1/PD-L1 | CELL LUNG-CANCER | MATERIALS SCIENCE, BIOMATERIALS | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | ENGINEERING, BIOMEDICAL | GROWTH | GENES | STROMAL FIBROBLASTS
Journal Article
Artificial Cells, Nanomedicine, and Biotechnology, ISSN 2169-1401, 12/2019, Volume 47, Issue 1, pp. 4194 - 4201
Aims: The present study was performed to investigate the efficacy and safety of anti-programmed death-1 (PD-1)/programmed death-ligand-1 (PD-L1) treatments in... 
Anti-PD-1/PD-L1 | pembrolizumab | atezolizumab | nivolumab | NSCLC
Journal Article
Expert Opinion on Biological Therapy, ISSN 1471-2598, 12/2019, Volume 19, Issue 12, pp. 1265 - 1274
Introduction: The efficacy of immune checkpoint inhibitors has been shown in many malignancies. Urothelial cancers have a high mutational load and also express... 
PD-L1 | Immune checkpoint inhibition | urothelial cancer | PD-1
Journal Article
OncoImmunology, ISSN 2162-402X, 12/2019, Volume 8, Issue 12, p. e1665977
Pleomorphic dermal sarcoma (PDS) is one of the most common sarcoma of the skin. Currently, limited treatment options exist for advanced stages of the disease.... 
Pembrolizumab | Pleomorphic dermal sarcoma (PDS) | PD-1 inhibition | sarcoma of the skin | immunotherapy
Journal Article
Expert Opinion on Biological Therapy, ISSN 1471-2598, 12/2019, Volume 19, Issue 12, pp. 1223 - 1228
Journal Article
Expert Opinion on Biological Therapy, ISSN 1471-2598, 12/2019, Volume 19, Issue 12, pp. 1247 - 1263
Introduction: Metastatic colorectal cancer (mCRC) is a challenging disease, whose systemic therapy has traditionally been based on a generalized population of... 
anti-PD-L1 | microsatellite instability | Anti-PD-1 | colorectal cancer | nivolumab | tumor mutational burden | immunotherapy | immune checkpoint inhibitors | anti-CTLA-4
Journal Article
RNA Biology, ISSN 1547-6286, 12/2019, Volume 16, Issue 12, pp. 1794 - 1805
The PDCD1 gene encodes PD-1, an important immune checkpoint protein and key immunotherapy target to treat cancer. PDCD1 is alternatively spliced to generate an... 
DDX5 | cancer | MATR3 | PDCD1 | antisense oligonucleotide | PD-1 | Index Medicus
Journal Article
Journal Article
JOURNAL FOR IMMUNOTHERAPY OF CANCER, ISSN 2051-1426, 07/2019, Volume 7, Issue 1, pp. 189 - 16
Background: Cancer immunotherapies are emerging as promising treatment strategies for ovarian cancer patients that experience disease relapse following first... 
Cancer vaccine | MRI | PD-1 blockade | IMMUNE-RELATED RESPONSE | Oncolytic virus | IMMUNOLOGY | CHALLENGES | Ovarian cancer | MELANOMA | ONCOLOGY | Immunotherapy | Adaptive immune resistance | GROWTH | RESISTANCE | T-CELLS | TALIMOGENE LAHERPAREPVEC | Cancer | Care and treatment | Usage | Genetic aspects | Metastasis | Research
Journal Article
SCIENTIFIC REPORTS, ISSN 2045-2322, 07/2019, Volume 9, Issue 1, pp. 10624 - 12
Journal Article
by Chen, YH and Yu, M and Zheng, YW and Fu, GP and Xin, G and Zhu, W and Luo, L and Burns, R and Li, QZ and Dent, AL and Zhu, N and Cui, WG and Malherbe, L and Wen, RR and Wang, DM
NATURE COMMUNICATIONS, ISSN 2041-1723, 09/2019, Volume 10, Issue 1, pp. 1 - 15
Journal Article